During the past decade, Riga East Clinical University Hospital conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 18 clinical trials were completed, i.e. on average, 47.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 16 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Riga East Clinical University Hospital" #1 sponsor was "Celgene" with 6 trials, followed by "Bayer" with 5 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Riga East Clinical University Hospital" #1 collaborator was "Accelovance" with 1 trials as a collaborator, "Erasmus Medical Center" with 1 trials as a collaborator, "GABO:mi" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "IHF GmbH - Institut für Herzinfarktforschung" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Riga East Clinical University Hospital" are "Crohn Disease" (6 trials), "Ulcerative Colitis" (6 trials), "Diabetic Retinopathy" (3 trials), "Atrial Fibrillation" (2 trials) and "Bladder Cancer" (2 trials). Many other conditions were trialed in "Riga East Clinical University Hospital" in a lesser frequency.

Most popular intervention types in "Riga East Clinical University Hospital" are "Drug" (34 trials), "Other" (9 trials), "Device" (4 trials), "Biological" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Ozanimod" (4 trials), "Apixaban" (2 trials), "Apixaban matching placebo" (2 trials) and "GED-0301" (2 trials). Other intervention names were less common.

The vast majority of trials in "Riga East Clinical University Hospital" are 44 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Riga East Clinical University Hospital". undefined are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Riga East Clinical University Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Riga East Clinical University Hospital, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".